Literature DB >> 14764920

Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease.

Xianyi Yu1, Kei-Ich Hirono, Fukiko Ichida, Kei-Ichiro Uese, Chen Rui, Sayaka Watanabe, Kazuhiro Watanabe, Ikuo Hashimoto, Tokimasa Kumada, Eikichi Okada, Masaru Terai, Atsuko Suzuki, Toshio Miyawaki.   

Abstract

Nitric oxide (NO) serves many vasoprotective roles, but the massive release of NO causes arterial wall degeneration. We investigated whether enhanced nitric oxide synthase (iNOS) expression in peripheral blood leukocytes and circulating endothelial cells mirrors the progression of coronary arterial lesions in 55 children with acute Kawasaki disease (KD), including 24 with and 31 without coronary artery lesions (CAL). Patients were treated with i.v. gamma-globulin at the time of diagnosis and blood samples were collected before and after treatment. The cellular origin of NO synthesis was determined by flow cytometric analysis of iNOS expression in peripheral blood, and by immunohistochemical analysis of circulating endothelial cells and coronary arteries. iNOS expression in neutrophils peaked at the time of diagnosis, but did not peak in monocytes until 2 wk post onset of disease. Levels were significantly higher in both cell types in patients with CAL (p = 0.001 and p = 0.035, respectively). In addition, the number of circulating endothelial cells and levels of iNOS expression were higher in patients with CAL (p = 0.011 and p = 0.012, respectively). Immunohistochemical analysis of the coronary arteries from three patients with acute KD revealed iNOS immunoreactivity in endothelial cells, as well as infiltrating monocytes/macrophages in the aneurysms. We conclude that the expression of iNOS in peripheral blood leukocytes, as well as circulating endothelial cells, correlates with the severity of coronary arterial wall injury and the progression of CAL in patients with acute KD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764920     DOI: 10.1203/01.PDR.0000113464.93042.A4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis.

Authors:  Yang Chen; Xiang Li; Krishna M Boini; Ashley L Pitzer; Erich Gulbins; Yang Zhang; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2014-11-15

3.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.

Authors:  Tetsuya Sano; Shunji Kurotobi; Kouji Matsuzaki; Takehisa Yamamoto; Ichiro Maki; Kazunori Miki; Shigetoyo Kogaki; Junichi Hara
Journal:  Eur J Pediatr       Date:  2006-08-01       Impact factor: 3.183

4.  MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.

Authors:  Kazuyoshi Saito; Hideyuki Nakaoka; Ichiro Takasaki; Keiichi Hirono; Seiji Yamamoto; Koshi Kinoshita; Nariaki Miyao; Keijiro Ibuki; Sayaka Ozawa; Kazuhiro Watanabe; Neil E Bowles; Fukiko Ichida
Journal:  Pediatr Res       Date:  2016-04-18       Impact factor: 3.756

5.  Increased nitric oxide production by neutrophils in early stage of Kawasaki disease.

Authors:  Ken Yoshimura; Kimiko Tatsumi; Anna Iharada; Shoji Tsuji; Ai Tateiwa; Masayuki Teraguchi; Hirotaro Ogino; Kazunari Kaneko
Journal:  Eur J Pediatr       Date:  2008-11-20       Impact factor: 3.183

6.  Elevated Inducible Nitric Oxide Levels and Decreased Hydrogen Sulfide Levels Can Predict the Risk of Coronary Artery Ectasia in Kawasaki Disease.

Authors:  Ruixia Song; Guiying Liu; Xiaohui Li; Wenya Xu; Jia Liu; Hongfang Jin
Journal:  Pediatr Cardiol       Date:  2015-10-24       Impact factor: 1.655

7.  Cardiovascular status after Kawasaki disease in the UK.

Authors:  V Shah; G Christov; T Mukasa; K S Brogan; A Wade; D Eleftheriou; M Levin; R M Tulloh; B Almeida; M J Dillon; J Marek; N Klein; P A Brogan
Journal:  Heart       Date:  2015-08-27       Impact factor: 5.994

8.  Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.

Authors:  Fu-Chen Huang; Ho-Chang Kuo; Ying-Hsien Huang; Hong-Ren Yu; Sung-Chou Li; Hsing-Chun Kuo
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-09       Impact factor: 2.483

9.  Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki disease.

Authors:  Xinjiang An; Haitao Lv; Jing Tian; Xiuhua He; Nan Ling
Journal:  Exp Ther Med       Date:  2016-01-27       Impact factor: 2.447

10.  MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease.

Authors:  Hideyuki Nakaoka; Keiichi Hirono; Seiji Yamamoto; Ichiro Takasaki; Kei Takahashi; Koshi Kinoshita; Asami Takasaki; Naonori Nishida; Mako Okabe; Wang Ce; Nariaki Miyao; Kazuyoshi Saito; Keijiro Ibuki; Sayaka Ozawa; Yuichi Adachi; Fukiko Ichida
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.